Dot Ai

Dot Ai Unveils ZiM, a Next-Gen IoT Tracking Technology

New product is poised to revolutionize asset tracking in logistics and supply chain management Press Release – December 11, 2024 – LAS VEGAS – SEE ID, Inc., doing business as Dot Ai (“Dot Ai”), an innovative startup in the asset intelligence technology space, has announced the launch of their new IoT tracking hardware. This next-generation technology product, ZiM (Zero Infrastructure Mesh, or “ZiM”) from Dot Ai, is … Continue reading Dot Ai Unveils ZiM, a Next-Gen IoT Tracking Technology

abbvie

AbbVie Completes Acquisition of Aliada Therapeutics

NORTH CHICAGO, Ill., Dec. 11, 2024 /PRNewswire/ — AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Aliada Therapeutics. With the completion of the acquisition, Aliada is now a part of AbbVie. Aliada’s lead investigational asset is ALIA-1758, an anti-pyroglutamate amyloid beta (3pE-Aβ) antibody, which is in development for the treatment of patients with Alzheimer’s disease and is currently in a Phase 1 clinical … Continue reading AbbVie Completes Acquisition of Aliada Therapeutics

Ignite Power

Ignite Power’s Subsidiary Westa Solar Secures $15 Million Investment from AFRIGREEN to Expand Across Africa’s C&I Sector

Press Release [Lagos] – Ignite Power has secured $15 million in senior debt financing from Afrigreen Debt Impact Fund (“AFRIGREEN”), a leading renewable energy investor focused on Africa, for its subsidiary Westa Solar, which specializes in commercial and industrial (C&I) solar energy. This substantial investment will fuel Ignite’s ambitious expansion plans, targeting vast, underserved market segments across West Africa by offering innovative and flexible financing … Continue reading Ignite Power’s Subsidiary Westa Solar Secures $15 Million Investment from AFRIGREEN to Expand Across Africa’s C&I Sector

exxonmobil

ExxonMobil announces plans to 2030 that build on its unique advantages

Expects to deliver growth potential of $20 billion in earnings and $30 billion in cash flow1 Key elements of ExxonMobil’s 2030 plan: Investing $27-$29 billion of cash capex in 2025 and $28-$33 billion annually in 2026-2030 to progress attractive long-term opportunities, with base planned capex roughly flat and reinvestment rate declining to 40% from 50% over the plan period5 Increasing Pioneer acquisition average annual synergies … Continue reading ExxonMobil announces plans to 2030 that build on its unique advantages

incardatherapeutics

InCarda Therapeutics Appoints Dr. Myles Greenberg as New CEO

Press Release – NEWARK, Calif. – December 10, 2024 – InCarda Therapeutics, a clinical stage biopharmaceutical company developing novel therapeutics for cardiac arrythmias, has announced that Myles Greenberg, MD, MBA will serve as its new president and CEO. Dr. Greenberg joins the company as it advances clinical development of its lead product, an orally inhaled treatment for the rapid conversion of recent-onset and symptomatic atrial fibrillation (AF) to sinus … Continue reading InCarda Therapeutics Appoints Dr. Myles Greenberg as New CEO